• bitcoinBitcoin(BTC)$77,246.000.05%
  • ethereumEthereum(ETH)$2,503.74-0.82%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$720.68-1.34%
  • rippleXRP(XRP)$1.35-1.02%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$100.93-1.07%
  • tronTRON(TRX)$0.3409840.28%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.00-0.68%
  • zcashZcash(ZEC)$1,109.72-2.54%
  • HyperliquidHyperliquid(HYPE)$78.38-2.85%
  • dogecoinDogecoin(DOGE)$0.084421-0.59%
  • RainRain(RAIN)$0.0153481.24%
  • moneroMonero(XMR)$533.820.64%
  • USDSUSDS(USDS)$1.000.00%
  • whitebitWhiteBIT Coin(WBT)$80.10-0.18%
  • chainlinkChainlink(LINK)$11.39-0.95%
  • leo-tokenLEO Token(LEO)$9.05-0.63%
  • cardanoCardano(ADA)$0.2083100.35%
  • stellarStellar(XLM)$0.179463-0.93%
  • Ethena USDeEthena USDe(USDE)$1.00-0.01%
  • daiDai(DAI)$1.000.00%
  • bitcoin-cashBitcoin Cash(BCH)$224.59-1.70%
  • USD1USD1(USD1)$1.00-0.02%
  • litecoinLitecoin(LTC)$54.601.38%
  • uniswapUniswap(UNI)$6.340.37%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.36-1.68%
  • CantonCanton(CC)$0.095541-2.09%
  • hedera-hashgraphHedera(HBAR)$0.0762402.11%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • avalanche-2Avalanche(AVAX)$7.420.16%
  • shiba-inuShiba Inu(SHIB)$0.000005-1.00%
  • nearNEAR Protocol(NEAR)$2.35-1.48%
  • suiSui(SUI)$0.72-0.81%
  • crypto-com-chainCronos(CRO)$0.058436-0.17%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • tether-goldTether Gold(XAUT)$4,349.46-0.01%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • MemeCoreMemeCore(M)$1.14-3.36%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • okbOKB(OKB)$113.21-0.14%
  • BittensorBittensor(TAO)$236.180.86%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.14-0.14%
  • aaveAave(AAVE)$126.970.61%
  • AsterAster(ASTER)$0.701.31%
  • pax-goldPAX Gold(PAXG)$4,353.83-0.02%
  • mantleMantle(MNT)$0.57-1.05%
  • BitwayBitway(BTW)$0.6723.19%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.056973-1.12%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Meet GeneGPT: A Novel Artificial Intelligence Method for Teaching LLMs to Use the Web APIs of the National Center for Biotechnology Information (NCBI) for Answering Genomics Questions

February 24, 2024
in AI & Technology
Reading Time: 5 mins read
A A
Meet GeneGPT: A Novel Artificial Intelligence Method for Teaching LLMs to Use the Web APIs of the National Center for Biotechnology Information (NCBI) for Answering Genomics Questions
ShareShareShareShareShare

The utility of large language models (LLMs) has been increasingly recognized, demonstrating remarkable capabilities in processing and interpreting vast datasets. These models have been instrumental in various tasks, from facilitating clinical trial matches to enabling sophisticated biomedical question-answering. A significant challenge they face is the production of plausible yet inaccurate responses, a phenomenon often attributed to the models’ inability to consult verified sources of information directly. This limitation underscores the pressing need for methods that can bridge the gap between LLMs and the accurate, specialized knowledge contained within biomedical databases.

LLMs typically must catch up when retrieving precise information from specialized fields such as genomics. The crux of the issue lies in the inherent limitations of these models to navigate and utilize domain-specific databases effectively. Recognizing this, researchers have been exploring innovative solutions that augment LLMs with the ability to directly access and interpret data from such specialized sources.

A groundbreaking approach in this context is the development of GeneGPT, a methodology that significantly enhances the ability of LLMs to access biomedical information. By integrating LLMs with Web APIs from the National Center for Biotechnology Information (NCBI), GeneGPT enables these models to perform targeted searches and retrieve information directly from NCBI’s databases. This method represents a pivotal advancement, as it allows LLMs to bypass the limitations of traditional database queries and now access the most current and relevant biomedical data.

GeneGPT’s methodology involves training LLMs to generate and execute API calls to NCBI’s Web APIs effectively. This is achieved through in-context learning and a specialized decoding algorithm to recognize and act upon these API requests. Such an approach not only facilitates real-time data retrieval but also significantly reduces the instances of inaccuracies in the model’s outputs. Moreover, by enabling direct access to NCBI’s databases, GeneGPT ensures that the information retrieved is current and highly relevant to the user’s query.

The performance of GeneGPT demonstrates superior accuracy and efficiency in retrieving biomedical information, outperforming existing models and methodologies. Notably, GeneGPT excels in handling complex, multi-hop questions that require sequential API calls, showcasing its ability to navigate through a series of interconnected queries to arrive at a precise answer. This level of performance is underlined by a comprehensive analysis of the model’s components, revealing the pivotal role that API demonstrations and documentation play in enhancing the learning process.

Beyond its immediate utility in the biomedical field, GeneGPT’s success heralds a new era for the application of LLMs across various domains. By bridging the gap between LLMs and specialized databases, GeneGPT addresses the challenge of inaccurate information retrieval and opens up new possibilities for leveraging LLMs in tasks requiring access to specific, verified knowledge. This advancement promises to expand the scope of LLM applications, making them more versatile and reliable tools for researchers and professionals alike.

In conclusion, GeneGPT represents a significant leap forward in the quest to enhance the capabilities of LLMs in biomedical research. By enabling these models to access and utilize specialized knowledge from NCBI’s databases directly, GeneGPT addresses a critical challenge in information retrieval. Its success not only underscores the potential of integrating LLMs with domain-specific tools but also paves the way for further innovations in the application of artificial intelligence in biomedical research and beyond. The development and implementation of GeneGPT mark a milestone in the journey towards more accurate, efficient, and reliable information retrieval systems, showcasing the transformative potential of augmented LLMs in navigating the vast and complex landscape of biomedical knowledge.


Check out the Paper and Github. All credit for this research goes to the researchers of this project. Also, don’t forget to follow us on Twitter and Google News. Join our 37k+ ML SubReddit, 41k+ Facebook Community, Discord Channel, and LinkedIn Group.

If you like our work, you will love our newsletter..

Don’t Forget to join our Telegram Channel


YOU MAY ALSO LIKE

If Your Laptop Trackpad Is Popping Out, Stop Using It Immediately

How To Get Your Cut Of PlayStation’s $7.85 Million Settlement

Sana Hassan, a consulting intern at Marktechpost and dual-degree student at IIT Madras, is passionate about applying technology and AI to address real-world challenges. With a keen interest in solving practical problems, he brings a fresh perspective to the intersection of AI and real-life solutions.


🚀 LLMWare Launches SLIMs: Small Specialized Function-Calling Models for Multi-Step Automation [Check out all the models]


Credit: Source link

ShareTweetSendSharePin

Related Posts

If Your Laptop Trackpad Is Popping Out, Stop Using It Immediately
AI & Technology

If Your Laptop Trackpad Is Popping Out, Stop Using It Immediately

September 13, 2026
How To Get Your Cut Of PlayStation’s .85 Million Settlement
AI & Technology

How To Get Your Cut Of PlayStation’s $7.85 Million Settlement

September 13, 2026
What Are Embeddings? How AI Represents Meaning as Numbers – Unite.AI
AI & Technology

What Are Embeddings? How AI Represents Meaning as Numbers – Unite.AI

September 13, 2026
AWS Introduces Pizza Bot: An Open Source Inbox for Background AI Agents
AI & Technology

AWS Introduces Pizza Bot: An Open Source Inbox for Background AI Agents

September 13, 2026
Next Post
Google explains why Gemini’s image generation feature overcorrected for diversity

Google explains why Gemini's image generation feature overcorrected for diversity

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Is The Stock Market About To Get Worse? (Don’t Panic!)

Is The Stock Market About To Get Worse? (Don’t Panic!)

September 11, 2026
Balancing AI Risks With the Race to Stay Ahead of China

Balancing AI Risks With the Race to Stay Ahead of China

September 12, 2026
Fujitsu Signs New Palantir AIP Agreement, Becomes Global FDE Partner – Unite.AI

Fujitsu Signs New Palantir AIP Agreement, Becomes Global FDE Partner – Unite.AI

September 10, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!